Results for ''
HDR UK welcomes the Chancellor of the Exchequer’s pledge of £650 million for the UK’s life sciences including £121 million to improve clinical trials to bring new medicines to patients faster.
EMPA-KIDNEY is an international clinical trial by Oxford Population Health scientists in collaboration with academics spanning eight countries. The study recruited over 6000 participants to...
In a commentary published today, HDR UK researchers describe how a key roadblock to using the UK’s rich resources of health data can be removed to make clinical trials faster and more efficient.
A large-scale clinical trial of a monoclonal antibody treatment for COVID-19 showed that it could reduce deaths by 21 per cent in people who had not mounted a natural antibody response of their own.
We explore how routinely collected health data may hold the key to super-charging how clinical trials are delivered, and in turn, how quickly we can bring improvements to people's lives.
Linking historic trial data with electronic health records allowed this dormant trial on the relationship between infant formula and cognitive ability to become reactivated - making it the first...
On the second anniversary of the RECOVERY trial, we look at how access to routine clinical healthcare data was a key element of its success in finding treatments for COVID-19. And how...
Overview Patient Reported Outcomes (PROs) can provide valuable evidence on the impact of disease and treatment on patients’ symptoms, function and quality of life. High-quality PRO data from...
DATA-CAN, the UKs Health Data Research Hub for Cancer, discusses how they work with patients and the public to deliver better outcomes for those living with cancer.
